A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Structured exercise after chemotherapy lowers colon cancer recurrence and boosts long-term survival, new trial shows.

The European Medicines Agency has confirmed suspension of marketing authorization for Pfizer's now-withdrawn Oxbryta for ...

Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...

Physicians and patient advocacy groups are rallying behind a renewed legislative effort in Congress to amend what they claim ...

Atezolizumab improved DFS and OS in ctDNA-positive MIBC patients, with a median DFS of 9.9 months vs 4.8 months for placebo. Serial ctDNA testing may offer a more accurate assessment of MRD and early ...

Botox is widely known to iron out wrinkles, but it could also help ease phantom limb pain in Ukrainian war amputees, ...